Cited by 279Hormonal Regulation and HypertensionObstructive Sleep Apnea ResearchBlood Pressure and Hypertension Studies

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.

Resistant Hypertension, Obesity, Sleep Apnea, and Aldosterone: Theory and Therapy

Goodfriend, Theodore L., Calhoun, David A.·2004·Hypertension

Open this paper in CoChat — free account

Abstract

Hypertension resistant to 2 antihypertensive drugs is more common among obese patients than among lean patients. The case we describe and the observations we report suggest that refractoriness among obese hypertensives is frequently caused by obstructive sleep apnea and/or inappropriately high plasma aldosterone levels. In other words, obese hypertensives may have sleep apnea, obese hypertensives without sleep apnea may have inappropriately elevated levels of plasma aldosterone, and a surprising number of obese patients with sleep apnea also have elevated levels of aldosterone. The mechanisms by which obesity and obstructive sleep apnea increase aldosterone levels and raise blood pressure are not understood, but sympathetic nervous system activation and production of nonclassical adrenal stimuli are two possibilities. Obstructive sleep apnea can be detected with a careful history and various sleep studies. Inappropriately elevated aldosterone levels can be detected by measuring the ratio of plasma aldosterone concentration to plasma renin activity. Successful treatment of these resistant hypertensives often can be achieved by devices that provide positive pressure to the upper airway to correct obstructive sleep apnea and by incorporating an aldosterone antagonist in the therapeutic regimen.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.hyp.0000116223.97436.e5

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2981 · Cited by 5,664
Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
Insulin Resistance in Essential Hypertension
Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M. A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., & Bevilacqua, S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708063170605 · Cited by 2,344
Hypertension and associated metabolic abnormalities–the role of insulin resistance and the sympathoadrenal system.
Reaven, G. M., Lithell, H., & Landsberg, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602083340607 · Cited by 1,435
Obesity and Systemic Oxidative Stress: Clinical Correlates of Oxidative Stress in The Framingham Study
Keaney, J. F., Larson, M. G., Vasan, R. S., Wilson, P. W. F., Lipinska, I., Corey, D., Massaro, J. M., Sutherland, P., Vita, J. A., & Benjamin, E. J. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000058402.34138.11 · Cited by 1,304
Regional adiposity and morbidity.
Kissebah, A. H., & Krakower, G. R. (1994) · Physiological Reviews · doi:10.1152/physrev.1994.74.4.761 · Cited by 1,132
Original Papers. Success and Predictors of Blood Pressure Control in Diverse North American Settings: The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Cushman, W. C., Ford, C. E., Cutler, J. A., Margolis, K. L., Davis, B. R., Grimm, R. H., Black, H. R., Hamilton, B. P., Holland, J., Nwachuku, C., et al. (2002) · The Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2002.02045.x · Cited by 979
Population-Based Study of Sleep-Disordered Breathing as a Risk Factor for Hypertension
Young, T. B. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440360178019 · Cited by 967
High prevalence of unrecognized sleep apnoea in drug-resistant hypertension
Logan, A. G., Perlikowski, S. M., Mente, A., Tisler, A., Tkacova, R., Niroumand, M., Leung, R. S. T., & Bradley, T. D. (2001) · Journal of Hypertension · doi:10.1097/00004872-200112000-00022 · Cited by 960
The Kidney, Hypertension, and Obesity
Hall, J. E. (2003) · Hypertension · doi:10.1161/01.hyp.0000052314.95497.78 · Cited by 868
Incidence and precursors of hypertension in young adults: The Framingham offspring study
Garrison, R. J., Kannel, W. B., Stokes, J., & Castelli, W. P. (1987) · Preventive Medicine · doi:10.1016/0091-7435(87)90087-9 · Cited by 789
Hyperaldosteronism Among Black and White Subjects With Resistant Hypertension
Calhoun, D. A., Nishizaka, M. K., Zaman, M. A., Thakkar, R. B., & Weissmann, P. (2002) · Hypertension · doi:10.1161/01.hyp.0000040261.30455.b6 · Cited by 763
Self-citation
EPLERENONE POST-ACUTE MYOCARDIAL INFARCTION HEART FAILURE EFFICACY AND SURVIVAL STUDY INVESTIGATORS. EPLERENONE, A SELECTIVE ALDOSTERONE BLOCKER, IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION
Pitt, B., Wj, R., Zannad, F. M., Neaton, J. D., Martínez, F. A., Roniker, B., Bittman, R. M., Hurley, S., Kleiman, J. H., & Gatlin, M. R. (2003) · Cited by 708
Augmented Resting Sympathetic Activity in Awake Patients With Obstructive Sleep Apnea
Carlson, J. T., Hedner, J. A., Elam, M., Ejnell, H., Sellgren, J., & Wallin, B. G. (1993) · CHEST Journal · doi:10.1378/chest.103.6.1763 · Cited by 681
Aldosterone induces a vascular inflammatory phenotype in the rat heart
Rocha, R., Rudolph, A. E., Frierdich, G. E., Nachowiak, D. A., Kekec, B. K., Blomme, E. A. G., McMahon, E. G., & Delyani, J. A. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01096.2001 · Cited by 653
The Effect of Weight Reduction on Blood Pressure, Plasma Renin Activity, and Plasma Aldosterone Levels in Obese Patients
Tuck, M. L., Sowers, J. R., Dornfeld, L., Kledzik, G. S., & Maxwell, M. H. (1981) · New England Journal of Medicine · doi:10.1056/nejm198104163041602 · Cited by 643
Intraadrenal interactions in the regulation of adrenocortical steroidogenesis.
Ehrhart-Bornstein, M., Hinson, J. P., Bornstein, S. R., Scherbaum, W. A., & Vinson, G. P. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.2.0326 · Cited by 600
Sympathetic Activity in Obese Subjects With and Without Obstructive Sleep Apnea
Narkiewicz, K., van de Borne, P. J. H., Cooley, R. L., Dyken, M. E., & Somers, V. K. (1998) · Circulation · doi:10.1161/01.cir.98.8.772 · Cited by 525
Efficacy of low-dose spironolactone in subjects with resistant hypertension
Nishizaka, M. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(03)01032-x · Cited by 500
Nocturnal Continuous Positive Airway Pressure Decreases Daytime Sympathetic Traffic in Obstructive Sleep Apnea
Narkiewicz, K., Kato, M., Phillips, B. G., Pesek, C. A., Davison, D. E., & Somers, V. K. (1999) · Circulation · doi:10.1161/01.cir.100.23.2332 · Cited by 491
Aldosterone: A Mediator of Myocardial Necrosis and Renal Arteriopathy
Rocha, R., Stier, C. T., Kifor, I., Ochoa-Maya, M. R., Rennke, H. G., Williams, G. H., & Adler, G. K. (2000) · Endocrinology · doi:10.1210/endo.141.10.7711 · Cited by 480
Effects of obstructive sleep apnea on endothelin-1 and blood pressure
Phillips, B. G., Narkiewicz, K., Pesek, C. A., Haynes, W. G., Dyken, M. E., & Somers, V. K. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917010-00010 · Cited by 462
The effects of glucose and insulin on renal electrolyte transport.
DeFronzo, R. A., Goldberg, M., & Agus, Z. S. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108463 · Cited by 454
Human adipocytes secrete mineralocorticoid-releasing factors
Ehrhart‐Bornstein, M., Lamounier‐Zepter, V., Schraven, A., Langenbach, J., Willenberg, H. S., Barthel, A., Hauner, H., McCann, S. M., Scherbaum, W. A., & Bornstein, S. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336140100 · Cited by 442
Regional Sympathetic Nervous Activity and Oxygen Consumption in Obese Normotensive Human Subjects
Vaz, M., Jennings, G., Turner, A., Cox, H., Lambert, G., & Esler, M. (1997) · Circulation · doi:10.1161/01.cir.96.10.3423 · Cited by 404
Neural mechanisms in human obesity-related hypertension
Rumantir, M. S., Vaz, M., Jennings, G. L., Collier, G., Kaye, D. M., Seals, D. R., Wiesner, G. H., Brunner-La Rocca, H. P., & Esler, M. D. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917080-00012 · Cited by 396
Minireview: Primary Aldosteronism—Changing Concepts in Diagnosis and Treatment
Young, W. F. (2003) · Endocrinology · doi:10.1210/en.2003-0279 · Cited by 365
Sympathetic and Cardiorenal Actions of Leptin
Haynes, W. G., Sivitz, W. I., Morgan, D. A., Walsh, S. A., & Mark, A. L. (1997) · Hypertension · doi:10.1161/01.hyp.30.3.619 · Cited by 351
Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea
Møller, D. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)03267-3 · Cited by 318
Regulation of Aldosterone Secretion
Quinn, S. J., & Williams, G. H. (1988) · Annual Review of Physiology · doi:10.1146/annurev.ph.50.030188.002205 · Cited by 315
Renin Activity and Blood Pressure in Response to Chronic Episodic Hypoxia
Fletcher, E. C., Bao, G., & Li, R. (1999) · Hypertension · doi:10.1161/01.hyp.34.2.309 · Cited by 261
Aldosterone Excretion Among Subjects With Resistant Hypertension and Symptoms of Sleep Apnea
Calhoun, D. A., Nishizaka, M. K., Zaman, M. A., & Harding, S. M. (2004) · Chest · doi:10.1378/chest.125.1.112 · Cited by 260
Self-citation
Dissociation Between Muscle and Skin Sympathetic Nerve Activity in Essential Hypertension, Obesity, and Congestive Heart Failure
Grassi, G., Colombo, M., Seravalle, G., Spaziani, D., & Mancia, G. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.64 · Cited by 256
Visceral Obesity and Insulin Resistance Are Associated with Plasma Aldosterone Levels in Women
Goodfriend, T. L., Kelley, D. E., Goodpaster, B. H., & Winters, S. J. (1999) · Obesity Research · doi:10.1002/j.1550-8528.1999.tb00418.x · Cited by 234
Self-citation
Sympathetic denervation blocks blood pressure elevation in episodic hypoxia.
Fletcher, E. C., Leßke, J., Čulman, J., Miller, C. C., & Unger, T. (1992) · Hypertension · doi:10.1161/01.hyp.20.5.612 · Cited by 233
The role of spironolactone in the treatment of patients with refractory hypertension
Ouzan, J. M., Perault, C., Lincoff, A. M., Carre, E., & Mertès, P. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02342-1 · Cited by 203
Location and regulation of rat angiotensinogen messenger RNA.
Cassis, L. A., Saye, J. A., & Peach, M. J. (1988) · Hypertension · doi:10.1161/01.hyp.11.6.591 · Cited by 192
Antihypertensive effect of α- and β-adrenergic blockade in obese and lean hypertensive subjects
Wofford, M. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)01293-6 · Cited by 184
The Effect of Sleep Apnea on Plasma and Urinary Catecholamines
Dimsdale, J. E., Coy, T. V., Ziegler, M. G., Ancoli‐Israel, S., & Clausen, J. L. (1995) · SLEEP · doi:10.1093/sleep/18.5.377 · Cited by 179
Blood pressure response to chronic episodic hypoxia: the renin-angiotensin system
Fletcher, E. C., Orolinova, N., & Bäder, M. (2002) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00152.2001 · Cited by 165
Postprandial Free Fatty Acid Kinetics Are Abnormal in Upper Body Obesity
Roust, L. R., & Jensen, M. D. (1993) · Diabetes · doi:10.2337/diab.42.11.1567 · Cited by 164
Immediate effects of arousal from sleep on cardiac autonomic outflow in the absence of breathing in dogs
Horner, R. L., Brooks, D., KOZAR, L. F., Tse, S., & Phillipson, E. A. (1995) · Journal of Applied Physiology · doi:10.1152/jappl.1995.79.1.151 · Cited by 160
Aldosterone in obesity
Goodfriend, T. L., Egan, B. M., & Kelley, D. E. (1998) · Endocrine Research · doi:10.3109/07435809809032689 · Cited by 143
Self-citation
Aldosterone and Spironolactone in Heart Failure
Weber, K. T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411009 · Cited by 128
Sleep Apnea Syndrome: A Possible Contributing Factor to Resistant Hypertension
Lavie, P., & Hoffstein, V. (2001) · SLEEP · doi:10.1093/sleep/24.6.721 · Cited by 126
Obesity and cardiovascular disease
Rexrode, K. M., Manson, J. E., & Hennekens, C. H. (1996) · Current Opinion in Cardiology · doi:10.1097/00001573-199609000-00007 · Cited by 119
Role for aldosterone in blood pressure regulation of obese adolescents
Rocchini, A. P., Katch, V. L., Grekin, R. J., Moorehead, C., & Anderson, J. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90845-3 · Cited by 112
Salt-regulating hormones in young normotensive obese subjects. Effects of saline load.
Licata, G., Volpe, M., Scaglione, R., & Rubattu, S. (1994) · Hypertension · doi:10.1161/01.hyp.23.1_suppl.i20 · Cited by 106
Are sleep-related breathing disorders important contributing factors to the production of essential hypertension?
Silverberg, D. S., & Oksenberg, A. (2001) · Current Hypertension Reports · doi:10.1007/s11906-001-0040-8 · Cited by 97
Aldosterone: Cardiovascular assault
Struthers, A. D. (2002) · American Heart Journal · doi:10.1067/mhj.2002.129969 · Cited by 84
A New Look at the Treatment of Severe Hypertension
Kincaid‐Smith, P., Fang, P., Laver, M. C., & Kincaid‐Smith, P. (1973) · Clinical Science · doi:10.1042/cs045075s · Cited by 56
Changes in Endocrine Activities Relative to Obesity in Patients with Essential Hypertension*
Hiramatsu, K., Yamada, T., Ichikawa, K., Izumiyama, T., & Nagata, H. (1981) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1981.tb02389.x · Cited by 55
An integrated approach to diagnosis and therapeutic management of patients with systolic heart failure in the Copenhagen metropolitan area
Galatius, S., Gustafsson, F., Nielsen, P. H., Atar, D., & Hildebrandt, P. R. (2002) · American Heart Journal · doi:10.1067/mhj.2002.123841 · Cited by 46
An oxidized derivative of linoleic acid affects aldosterone secretion by adrenal cells in vitro
Goodfriend, T. L., Ball, D. L., & Gardner, H. W. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2002.0414 · Cited by 39
Self-citation
Diuretic treatment of resistant hypertension.
Ramsay, L. E., Silas, J. H., & Freestone, S. H. (1980) · BMJ · doi:10.1136/bmj.281.6248.1101 · Cited by 34
Familial Obesity, Sympathetic Activation and Blood Pressure Level
Masuo, K., Mikami, H., Ogihara, T., & Tuck, M. L. (2001) · Blood Pressure · doi:10.1080/08037050152669701 · Cited by 26
TheJournaland Its Owner — Resolving the Crisis
Angell, M. E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411008 · Cited by 25
Effects of treatment of obstructive sleep apnea on circadian hemodynamics
Voogel, A. J., van Steenwijk, R. P., Karemaker, J. M., & van Montfrans, G. A. (1999) · Journal of the Autonomic Nervous System · doi:10.1016/s0165-1838(99)00039-9 · Cited by 25
Influence of Spironolactone on Endogenous Steroid Metabolism in Man
Abshagen, U., Spörl, S., Schöneshöfer, M., L’age, M., Rennekamp, H., & Oelkers, W. (1976) · Clinical Science · doi:10.1042/cs051307s · Cited by 16

Research works printed but not linked: 7

10.1161/hyp.31.1.64 · DOI
10.1161/circ.96.10.3423 · DOI
10.1161/hyp.30.3.619 · DOI
10.1161/circ.98.8.772 · DOI
10.1161/circ.100.23.2332 · DOI
10.1161/hyp.34.2.309 · DOI
Scavo D, Borgia C, Iacobelli A. Aspetti di funzione corticosurrenalica nell obesita. Folia Endocrinol. 1968; 21: 307–310.

Sorted by citations

The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
Funder, J. W., Carey, R. M., Mantero, F., Murad, M. H., Reincke, M., Shibata, H., Stowasser, M., & Young, W. F. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4061 · Cited by 2,925
Therapeutic Peptides: Current Applications and Future Directions
Wang, L., Wang, N., Zhang, W., Cheng, X., Yan, Z., Shao, G., Wang, X., Wang, R., & Fu, C. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00904-4 · Cited by 2,131
Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline
Funder, J. W., Carey, R. M., Fardella, C., Gomez-Sanchez, C. E., Mantero, F., Stowasser, M., Young, W. F., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0104 · Cited by 1,554
Sleep Apnea and Cardiovascular Disease
Somers, V. K., White, D. P., Amin, R. S., Abraham, W. T., Costa, F., Culebras, A., Daniels, S. R., Floras, J. S., Hunt, C. E., Olson, L. J., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.002 · Cited by 1,530
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J. P., Dralle, H., Ebeling, P. R., Melmed, S. K., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,500

See all 279

Authors: Goodfriend, T. L., & Calhoun, D. A.
Affiliations: University of Wisconsin–Madison (US)
ORCID: Calhoun, David A.
Venue: Hypertension
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2004-03
Volume: 43
Issue: 3
Pages: 518-524
ISSN: 0194-911X (ISSN-L)
1524-4563
DOI: 10.1161/01.hyp.0000116223.97436.e5
OpenAlex: W2114339665
Cited by: 279
References: 61
Citations by year: 2026: 2 · 2025: 4 · 2024: 4 · 2023: 1 · 2022: 9 · 2021: 3 · 2020: 7 · 2019: 12 · 2018: 11 · 2017: 11 · 2016: 6 · 2015: 14 · 2014: 27 · 2013: 11 · 2012: 21
FWCI: 10.32
Type: journal article
Language: en
Open access: closed
Locations: Hypertension (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Keywords: resistant hypertension, obesity, obstructive sleep apnea, plasma aldosterone, aldosterone-renin ratio, sympathetic activation, mineralocorticoid receptor antagonists, blood pressure regulation
MeSH terms: Aldosterone, Antihypertensive Agents, Drug Resistance, Humans, Hypertension, Male, Middle Aged, Models, Theoretical, Obesity, Sleep Apnea Syndromes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Resistant Hypertension, Obesity, Sleep Apnea, and Aldosterone: Theory and Therapy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks